STAT3 and hepatocellular carcinoma: Interestingly, HCC co-cultured with HepLPCs and HCC exposed to the combination of Notch inhibitor DAPT and STAT3 inhibitor ruxolitinib exhibited a similar gene expression signature (Fig. 4E, F).